Haemato AG Working Capital to Net Assets Ratio
Haemato AG working capital to net assets ratio. Haemato AG (HAEK) has a Working Capital to Net Assets ratio of 28.9% as of December 2022. Working capital of €42.50 Million (current assets of €69.27 Million minus current liabilities of €26.77 Million) is measured against net assets of €147.17 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check HAEK goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Haemato AG (2021–2022)
Working capital to net assets ratio of Haemato AG from 2021 to 2022. This chart shows how Haemato AG's Working Capital to Net Assets ratio has evolved across 2 annual periods from 2021 to 2022. As of December 2022, the ratio stands at 28.9%, reflecting working capital of €42.50 Million against net assets of €147.17 Million EUR. See how many days can Haemato AG fund operations to measure how many days the company can operate on defensive assets alone.
Haemato AG Working Capital to Net Assets Ratio by Year (2021–2022)
Haemato AG working capital to net assets ratio by year from 2021 to 2022. The table below presents the year-by-year Working Capital to Net Assets ratio for Haemato AG from 2021 to 2022, covering 2 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see HAEK total asset value.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 28.9% | €42.50 Million | €147.17 Million | €69.27 Million | €26.77 Million | ▼ -1.5 pp |
| 2021 | 30.4% | €43.98 Million | €144.73 Million | €81.07 Million | €37.09 Million | — |